Moderna's early-stage human trial for a coronavirus vaccine produced antibodies in all 45 participants. https://t.co/dxLqAMuHak— CNBC (@CNBC) May 18, 2020
Moderna's early-stage human trial for a coronavirus vaccine produced antibodies in all 45 participants. https://t.co/dxLqAMuHak